Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
This article explains why benchmark returns can differ from index returns and what this means for investors evaluating results.
26,521 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Weeks after elon musk called anthropic, SpaceX lands a $4 billion data center deal with Anthropic, signaling a shift ...
Merlin's chief technology officer argues that autonomous systems could redefine aviation safety and national security...
July brought steadier ground for stocks as AI chip makers led a tech rally. This guide breaks down the drivers, what ...
NVIDIA signals a potential shift in its OpenAI investment with new discussions about winding down the stake. The news...
A potential iran peace deal could ease energy pressures and ignite a renewed risk-on rally across stocks, with airlin...
A big star leaving a major project isn’t just showbiz drama. It’s a real-world reminder to guard your finances with a...
Analysts are revising upward expectations for the Q2 earnings season, driven by energy and technology strength, a rar...
A new Stanford study finds tax refunds do little to blunt the impact of higher gasoline prices on American households...
May 2026 housing starts declined sharply, reinforcing the view that zoning laws won’t help near-term growth amid a st...
Midday trading shows the stock market today under pressure from higher yields and inflation fears. This guide explain...
A veteran observer warns that AI's impact extends beyond jobs, threatening cultural norms and household finances. The...